ELANNYSE
Elanco Animal Health Incorporated
$
0.000.00%
15-min delay
Open$
Prev Close$
Market Cap$10.85B
EPS$0.94
EarningsAug 10, 2026
DAY RANGE
$0.00$0.00
Key Statistics
Full Stats
Market Cap$10.85B
Enterprise Value$14.42B
P/E Ratio (TTM)
P/S Ratio2.20
P/B Ratio1.67
Forward P/E
EPS (TTM)$-0.49
EPS (FY)$0.94
Revenue (TTM)$4.89B
Profit Margin-4.95%
Operating Margin6.13%
ROE-3.67%
Debt/Equity0.61
Avg Vol (30d)6.1M
Beta (1Y)1.39
Beta (3Y)2.49
Beta (5Y)1.69
Shares Out499.45M
Float495.06M
Dividend
Next EarningsAug 10, 2026
Short Interest
52-Week Range
$0.00
$12.90$27.72

Latest News
All
Company Info

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Websiteelanco.com
SectorHealth Technology
Employees9000
Phone877 352 6261
Address2500 Innovation Way
Greenfield, IN, 46140
ISINUS28414H1032
2500 Innovation Way, Greenfield, IN
Open in Maps
Analyst Consensus